(MedPage Today) -- Local ablation may allow patients with non-small cell lung cancer who experience limited progression on tyrosine kinase inhibitors to continue to derive benefit from the drugs, a small study suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment